Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors

Summary

This clinical study is a real-world exploratory study to observe the safety and initial effectiveness of DC-CTL cells combined with conventional anti-tumor therapy in patients with colorectal cancer, esophageal cancer, lung cancer, liver cancer, breast cancer and other solid tumors.

Timeline

Start

2025-03-11

Primary completion

2026-04-01

Completion

2026-04-01

Drugs

Indications